In late February, the FDA warned the public that injectable terbutaline should not be used in pregnant women for prevention...
Read MoreSince taking over the majority in the House of Representatives, many Republicans have vowed to address what they say is...
Read MoreWe had previously blogged about the sorry state of regulatory oversight of manufacturers of temporomandibular joint (TMJ) implants. The good news...
Read MoreLate last year, the FDA issued a warning against the use of the injectable form of dolasetron mesylate (Anzemet) to...
Read MoreA Colorado study published late last year found that the incidence of surgeons operating on the wrong patient or at...
Read MoreMore than 10 million Americans suffer from a condition known temporomandibular joint disorder, or TMJ, which causes varying levels of...
Read MoreGadolinium-based contrast agents (GBCAs) are intravenous drugs used in diagnostic imaging procedures to enhance the quality of magnetic resonance imaging...
Read MoreFDA notified healthcare professionals of the class 1 recall of the SIGMA Spectrum Infusion Pump Model 35700, which is used...
Read MoreA study released earlier this year by the the Society of Actuaries (SOA) estimated that measurable medical errors cost the...
Read MoreA new study emanating from Harvard Medical School found that as many as 17 percent of the doctors surveyed had...
Read More
